Showing 13,701 - 13,720 results of 133,879 for search '(( 2 we decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.73s Refine Results
  1. 13701

    Data Sheet 2_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Background<p>The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted extensive research into factors influencing the onset and severity of the disease. …”
  2. 13702

    Supplementary file 1_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.docx by Filippos S. Kardaras (18330696)

    Published 2025
    “…Background<p>The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted extensive research into factors influencing the onset and severity of the disease. …”
  3. 13703

    Data Sheet 4_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Background<p>The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted extensive research into factors influencing the onset and severity of the disease. …”
  4. 13704

    Data Sheet 1_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Background<p>The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted extensive research into factors influencing the onset and severity of the disease. …”
  5. 13705

    Data Sheet 3_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Background<p>The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted extensive research into factors influencing the onset and severity of the disease. …”
  6. 13706
  7. 13707

    DataSheet_1_Population-based study of the durability of humoral immunity after SARS-CoV-2 infection.pdf by David Peterhoff (5069261)

    Published 2023
    “…However, there is substantial uncertainty about their durability. We investigated levels and temporal change of SARS-CoV-2 antibody quantity and quality. …”
  8. 13708
  9. 13709
  10. 13710
  11. 13711
  12. 13712

    Competitive Arsenate and Phosphate Adsorption on Ferrihydrite as Described by the CD-MUSIC Model by Jon Petter Gustafsson (1851535)

    Published 2022
    “…This causes a flatter adsorption isotherm for As­(V), which leads to a stronger As­(V) adsorption as the As­(V)-to-Fe ratio decreases, compared to that for PO<sub>4</sub>.…”
  13. 13713

    Pharmacological Inhibition of Dynamin II Reduces Constitutive Protein Secretion from Primary Human Macrophages by Maaike Kockx (154125)

    Published 2014
    “…We conclude that pharmacological inhibitors of dynamin II modulate the constitutive secretion of macrophage apoE as a class effect, and that their capacity to modulate protein secretion may affect a range of biological processes.…”
  14. 13714

    Overexpression of G6PD rescued the high glucose-indueed decrease in the antioxidant enzymes and reduced ROS level in endothelial cells. by Zhaoyun Zhang (118032)

    Published 2012
    “…Endothelial cells were infected with either Ad2-G6PD (MOI: 5) or empty vector control (Laz). A: G6PD protein was significantly increased with adenovirus infection in endothelial cells exposed to high glucose. …”
  15. 13715

    Membrane Perturbations and Assay Interferences by Ivermectin Explain Its In Vitro SARS-CoV‑2 Antiviral Activities and Lack of Translatability by Richard T. Eastman (6051881)

    Published 2025
    “…The antiparasitic drug ivermectin was proposed as a repurposed drug for the treatment of SARS-CoV-2 infection based on in vitro studies, but proved ineffective in high-quality clinical trials. …”
  16. 13716

    Membrane Perturbations and Assay Interferences by Ivermectin Explain Its In Vitro SARS-CoV‑2 Antiviral Activities and Lack of Translatability by Richard T. Eastman (6051881)

    Published 2025
    “…The antiparasitic drug ivermectin was proposed as a repurposed drug for the treatment of SARS-CoV-2 infection based on in vitro studies, but proved ineffective in high-quality clinical trials. …”
  17. 13717

    Membrane Perturbations and Assay Interferences by Ivermectin Explain Its In Vitro SARS-CoV‑2 Antiviral Activities and Lack of Translatability by Richard T. Eastman (6051881)

    Published 2025
    “…The antiparasitic drug ivermectin was proposed as a repurposed drug for the treatment of SARS-CoV-2 infection based on in vitro studies, but proved ineffective in high-quality clinical trials. …”
  18. 13718
  19. 13719

    DataSheet2_Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment.zip by Jing-Li Xu (12553285)

    Published 2022
    “…We observed that the combination of TRMBE and 5-FU decreased the risk of liver metastasis in vivo. …”
  20. 13720